课题基金 / 基金详情

Evaluating the importance of autophagy/xenophagy in protecting the intestinal epithelium in Crohn s Disease

Evaluating the importance of autophagy/xenophagy in protecting the intestinal epithelium in Crohn s Disease
评估自噬/异体自噬在保护克罗恩病肠上皮中的重要性
批准号:
G0800759/1
负责人:
Jack Satsangi
金额:
$42.11万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2009
资助国家:
英国
项目状态:
已结题
起止时间:
2009 至 --

项目摘要

项目成果

Jack Satsangi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The inflammatory bowel diseases (IBD) are disabling life-long illnesses which are common in the Western world. Typical symptoms common to both illnesses include abdominal pain, weight loss, and diarrhoea. There are two main types of inflammatory bowel disease: Crohn?s disease (CD) and ulcerative colitis (UC). The cause of these illnesses is not certain, but it is now very clear that each condition is influenced by a number of genetic risk factors as well as environmental factors. These include the presence of bacteria in the bowel and smoking habit. Recently, great progress has been made in identifying several new genetic risk factors involved in Crohn?s disease. Two of the most recently identified genes are involved in a process called autophagy, a mechanism by which cells conserve or recycle specific proteins to keep themselves alive in conditions of starvation, or under specific environmental ?stressors?. There is some evidence that autophagy might also be involved in the maintenance of a healthy gut, removing or killing ?bad? bacteria and allowing ?good? bacteria to live there. Changes in the regulation of the autophagy pathway might upset this delicate balance or allow ?good? bacteria to produce unwanted responses from the gut cells, leading to inflammation. In a series of laboratory experiments, we aim to investigate this pathway and to clarify how function is changed in CD patients and the effect of different environmental ?stressors?, and of genetic alterations. Results will indicate whether this pathway is involved in the cause or development of CD and may also indicate the molecular pathways involved which could potentially lead to the development of new drug therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Randomised Controlled Trial of 6-Mercaptopurine versus placebo to prevent recurrence of Crohn's disease following surgic
  • 批准号:
    G0600329/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $188.51万
  • 财政年份:
    2007
  • 负责人:
    Jack Satsangi
  • 依托单位:
国内基金
海外基金
体数据表达与绘制的新方法研究
  • 批准号:
    61170206
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2011
  • 负责人:
    周秉锋
  • 依托单位: